Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study
Authors:
Open Access
- 29 December 2020
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 21 (1) , 87-96
Abstract
: BI 695501 is an approved biosimilar to Humira® reference product (RP). : In this randomized Phase III trial (VOLTAIRE-PSO), patients with moderate-to-severe chronic plaque psoriasis received BI 6...Keywords
Funding Information
- Boehringer Ingelheim
This publication has 19 references indexed in Scilit:
- Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III studyJournal of the American Academy of Dermatology, 2017
- Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjectsExpert Opinion on Investigational Drugs, 2016
- Adalimumab: A Review in Chronic Plaque PsoriasisDrugs, 2015
- The cost of biologics for psoriasis is increasingDrugs in Context, 2014
- Efficacy and Cost-Efficacy of Biologic Therapies for Moderate to Severe Psoriasis: A Meta-Analysis and Cost-Efficacy Analysis Using the Intention-to-Treat PrincipleBioMed Research International, 2014
- Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal StudiesJournal of Cutaneous Medicine and Surgery, 2009
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2008
- Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)British Journal of Dermatology, 2007
- Psoriasis and its managementBMJ, 2006
- Psoriasis causes as much disability as other major medical diseasesJournal of the American Academy of Dermatology, 1999